ASO vs. AS: Which Stock Is the Better Value Option?Zacks Investment Research · 3 days ago
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026GuruFocus · Oct 17, 2026
Amer Sports Chief Strategy Officer Exercises Options to Acquire More than $7 Million Shares. Is This a Signal to Buy AS?The Motley Fool · Oct 12, 2026
New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel DiseaseGuruFocus · Oct 11, 2026
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV CongressGuruFocus · Sep 30, 2026
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic ArthritisGuruFocus · Sep 22, 2026Amer Sports, Inc. is a global enterprise dedicated to the creation, production, promotion, and sale of athletic equipment, clothing, footwear, and related accessories. The company's extensive reach covers Europe, the Middle East, Africa, the Americas, China, and the wider Asia Pacific region. Its operations are structured into three main divisions.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 18, 2026 | $0.11 | $0.22 | Beat |
| May 19, 2026 | $0.31 | $0.38 | Beat |
| Feb 24, 2026 | $0.28 | $0.31 | Beat |
| Nov 18, 2025 | $0.25 | $0.33 | Beat |
| Aug 19, 2025 | $0.02 | $0.06 | Beat |
| May 20, 2025 | $0.15 | $0.27 | Beat |